المؤلفون: Rabaneda-Lombarte, Neus, Faura, Júlia, Ezcurra-Díaz, Garbiñe, Álvarez-Larruy, Marta, Vidal-de Francisco, Diana, Maisterra Santos, Olga, Montaner Villalonga, Joan, Olive-Gadea, Marta, Rubiera Del Fueyo, Marta A

المساهمون: Institut Català de la Salut, Rabaneda-Lombarte N, Ezcurra-Díaz G, Álvarez-Larruy M Hospital Universitari and Institut de Recerca Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. Faura J Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Olivé-Gadea M, Rubiera M, Maisterra O Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vidal-de Francisco D Complejo Hospitalario de Jaén, Jaén, Spain. Montaner J Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Hospital Universitario Virgen Macarena, Sevilla, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Medicaments antibacterians - Ús terapèutic, Pneumònia - Diagnòstic, Malalties cerebrovasculars - Diagnòstic, DISEASES::Respiratory Tract Diseases::Lung Diseases::Pneumonia, DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Cerebrovascular Disorders::Stroke, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents, ENFERMEDADES::enfermedades respiratorias::enfermedades pulmonares::neumonía, ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos cerebrovasculares::accidente cerebrovascular, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos

وصف الملف: application/pdf

العلاقة: Frontiers in Neurology;15; https://doi.org/10.3389/fneur.2024.1358628Test; info:eu-repo/grantAgreement/ES/PE2017-2020/PI17%2F02130; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/RD21%2F0006%2F0007; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/RD21%2F0006%2F0015; Rabaneda-Lombarte N, Faura J, Ezcurra-Díaz G, Olivé-Gadea M, Álvarez-Larruy M, Vidal-De Francisco D, et al. Stroke-associated pneumonia according to mCDC criteria: impact on prognosis and antibiotic therapy. Front Neurol. 2024 Feb 28;15:1358628.; https://hdl.handle.net/11351/11229Test

الإتاحة: https://doi.org/10.3389/fneur.2024.1358628Test
https://hdl.handle.net/11351/11229Test

المؤلفون: Bastard, Paul, Gervais, Adrian, Taniguchi, Maki, Saare, Liisa, Särekannu, Karita, le voyer, tom, Garcia-Prat, Marina, Colobran, Roger, Pau-Parra, Alba, Rivière, Jacques G., Soler-Palacin, Pere

المساهمون: Institut Català de la Salut, Bastard P Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France. University Paris Cité, Imagine Institute, Paris, France. St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, Assistance Publique-Hôspitaux de Paris (AP-HP), Paris, France. Gervais A, Le Voyer T Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France. University Paris Cité, Imagine Institute, Paris, France. Taniguchi M Dept. of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Saare L Dept. of Pediatrics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia. Särekannu K Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia. Garcia-Prat M, Parra-Martínez A, Rivière JG, Soler-Palacin P Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Colobran R Servei d’Immunologia, Àrea de Genètica Clínica i Molecular, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: COVID-19 (Malaltia), Autoanticossos, Pneumònia, Infants, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, NAMED GROUPS::Persons::Age Groups::Child, DISEASES::Respiratory Tract Diseases::Lung Diseases::Pneumonia, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Autoantibodies, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño, ENFERMEDADES::enfermedades respiratorias::enfermedades pulmonares::neumonía, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::autoanticuerpos

وصف الملف: application/pdf

العلاقة: Journal of Experimental Medicine;221(2); https://doi.org/10.1084/jem.20231353Test; Bastard P, Gervais A, Taniguchi M, Saare L, Särekannu K, Le Voyer T, et al. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. J Exp Med. 2024 Feb 5;221(2):e20231353.; https://hdl.handle.net/11351/10999Test; 001136834800001

الإتاحة: https://doi.org/10.1084/jem.20231353Test
https://hdl.handle.net/11351/10999Test

المؤلفون: Longhitano, Yaroslava, Zanza, Christian, Romenskaya, Tatsiana, Saviano, Angela, Persiano, Tonia, Leo, Mirco, Rello Condomines, Jordi

المساهمون: Institut Català de la Salut, Longhitano Y Department of Anesthesiology and Intensive Care, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. Foundation of “Ospedale Alba-Bra Onlus”, Verduno, Italy. Department of Emergency Medicine, Anesthesia and Critical Care Medicine, Michele and Pietro Ferrero Hospital, Verduno, Italy. Zanza C Department of Anesthesiology and Intensive Care, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. Foundation of “Ospedale Alba-Bra Onlus”, Verduno, Italy. Department of Emergency Medicine, Anesthesia and Critical Care Medicine, Michele and Pietro Ferrero Hospital, Verduno, Italy. Department of Emergency Medicine, Polyclinic Agostino Gemelli University Hospital, Rome, Italy. Romenskaya T, Leo M Department of Anesthesiology and Intensive Care, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. Saviano A Department of Emergency Medicine, Polyclinic Agostino Gemelli University Hospital, Rome, Italy. Persiano T Department of Medicine and Emergency Medicine, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. Rello J Grup de Recerca Clínica/Innovació en la Pneumònia i Sèpsia (CRIPS), Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Clinical Research in the ICU, CHU Nimes, Universite de Nimes-Montpellier, Montpellier, France, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pneumònia - Tractament, COVID-19 (Malaltia) - Complicacions, Oxigenoteràpia, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, Other subheadings::Other subheadings::Other subheadings::/complications, DISEASES::Respiratory Tract Diseases::Lung Diseases::Pneumonia, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Respiratory Therapy::Oxygen Inhalation Therapy, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones, ENFERMEDADES::enfermedades respiratorias::enfermedades pulmonares::neumonía, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia respiratoria::tratamiento por inhalación de oxígeno

وصف الملف: application/pdf

العلاقة: Journal of Clinical Medicine;11; https://doi.org/10.3390/jcm11010179Test; Longhitano Y, Zanza C, Romenskaya T, Saviano A, Persiano T, Leo M, et al. Single-Breath Counting Test Predicts Non-Invasive Respiratory Support Requirements in Patients with COVID-19 Pneumonia. J Clin Med. 2022 Dec 29;11:179.; https://hdl.handle.net/11351/8640Test; 000760255700001

الإتاحة: https://doi.org/10.3390/jcm11010179Test
https://hdl.handle.net/11351/8640Test

المؤلفون: Cilloniz, Catia, Peroni, Héctor José, Gabarrús, Albert, Garcia-Vidal, Carolina, Pericàs Pulido, Juan Manuel, Bermejo-Martin, Jesús

المساهمون: Institut Català de la Salut, Cilloniz C, Gabarrús A Department of Pneumology, Hospital Clinic of Barcelona, Barcelona, Spain. August Pi i Sunyer Biomedical Research Institute–IDIBAPS, University of Barcelona, Barcelona, Spain. Biomedical Research Networking Centres in Respiratory Diseases (Ciberes) Barcelona, Spain. Peroni HJ Respiratory Medicine Unit, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. Emergency Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. García-Vidal C Infectious Disease Department, Hospital Clinic of Barcelona, Barcelona, Spain. Pericàs JM Infectious Disease Department, Hospital Clinic of Barcelona, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Bermejo-Martin J Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, Salamanca, Spain. Hospital Universitario Río Hortega de Valladolid, Valladolid, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pneumònia adquirida a la comunitat - Mortalitat, Limfopènia - Diagnòstic, DISEASES::Bacterial Infections and Mycoses::Infection::Community-Acquired Infections, DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases::Leukocyte Disorders::Leukopenia::Lymphopenia, DISEASES::Respiratory Tract Diseases::Lung Diseases::Pneumonia, Other subheadings::Other subheadings::Other subheadings::Other subheadings::/mortality, ENFERMEDADES::infecciones bacterianas y micosis::infección::infecciones adquiridas en la comunidad, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas::trastornos leucocitarios::leucopenia::linfopenia, ENFERMEDADES::enfermedades respiratorias::enfermedades pulmonares::neumonía, Otros calificadores::Otros calificadores::Otros calificadores::Otros calificadores::/mortalidad

وصف الملف: application/pdf

العلاقة: Open Forum Infectious Diseases;8(6); https://doi.org/10.1093/ofid/ofab169Test; Cilloniz C, Peroni HJ, Gabarrús A, García-Vidal C, Pericàs JM, Bermejo-Martin J, et al. Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis. Open Forum Infect Dis. 2021 Jun;8(6):ofab169.; https://hdl.handle.net/11351/7314Test

الإتاحة: https://doi.org/10.1093/ofid/ofab169Test
https://hdl.handle.net/11351/7314Test

المؤلفون: Moreno, Gerard, Rodríguez, Alejandro, Sole Violan, Jordi, Martin-Loeches, Ignacio, Díaz, Emili, Bodí, María, Papiol Gallofré, Elisabeth

المساهمون: Institut Català de la Salut, Moreno G, Rodríguez A, Bodí M Critical Care Dept, Hospital Universitari de Tarragona Joan XXIII, URV/IISPV/CIBERES, Tarragona, Spain. Sole-Violán J Critical Care Dept, Hospital Universitario de Gran Canaria Dr Negrín, CIBERES, Las Palmas de Gran Canaria, Spain. Martín-Loeches I Dept of Anaesthesia and Critical Care, St James’s University Hospital, Trinity Centre for Health Sciences, Multidisciplinary Intensive Care Research Organisation (MICRO), Dublin, Ireland. Díaz E Critical Care Dept, Hospital Parc Taulí, CIBERES, Sabadell, Spain. Papiol E Unitat de Cures Intensives (UCI), Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pneumònia vírica, Medicaments antivírics, Supervivència, DISEASES::Respiratory Tract Diseases::Lung Diseases::Pneumonia, Other subheadings::Other subheadings::Other subheadings::/drug therapy, HEALTH CARE::Population Characteristics::Demography::Vital Statistics::Mortality::Survival Rate, ATENCIÓN DE SALUD::Características de la Población::demografía::estadísticas vitales::mortalidad::tasa de supervivencia, ENFERMEDADES::enfermedades respiratorias::enfermedades pulmonares::neumonía, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

وصف الملف: application/pdf

العلاقة: ERJ Open Research;7(1); https://openres.ersjournals.com/content/7/1/00888-2020Test; Moreno G, Rodríguez A, Sole-Violán J, Martín-Loeches I, Díaz E, Bodí M, et al. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia. ERJ Open Res. 2021 Mar 8;7(1):00888-2020.; https://hdl.handle.net/11351/6077Test; 000642370600050

الإتاحة: https://doi.org/10.1183/23120541.00888-2020Test
https://hdl.handle.net/11351/6077Test

المؤلفون: Carbonell, Raquel, Moreno, Gerard, Martin-Loeches, Ignacio, Gomez-Bertomeu, Frederic, Sarvisé, Carolina, Gómez, Josep, Papiol Gallofré, Elisabeth

المساهمون: Institut Català de la Salut, Carbonell R, Moreno G Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain. Martín-Loeches I Department of Anaesthesia and Critical Care, St James’s University Hospital, Trinity Centre for Health Sciences, Multidisciplinary Intensive Care Research Organization (MICRO), Dublin 8, Ireland. Gomez-Bertomeu F, Sarvisé C Microbiology, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain. Gómez J Tarragona Health Data Research Working Group (THeDaR)-ICU Hospital Joan XXIII, 43005 Tarragona, Spain. Papiol E Servei de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pneumònia, Marcadors bioquímics, Prognosi, DISEASES::Respiratory Tract Diseases::Lung Diseases::Pneumonia, CHEMICALS AND DRUGS::Biological Factors::Biomarkers, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis, ENFERMEDADES::enfermedades respiratorias::enfermedades pulmonares::neumonía, COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico

وصف الملف: application/pdf

العلاقة: Antibiotics;10; https://doi.org/10.3390/antibiotics10040350Test; Carbonell R, Moreno G, Martín-Loeches I, Gomez-Bertomeu F, Sarvisé C, Gómez J, et al. Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia. Antibiotics. 2021 Mar 26;10:350.; https://hdl.handle.net/11351/6627Test; 000642650300001

الإتاحة: https://doi.org/10.3390/antibiotics10040350Test
https://hdl.handle.net/11351/6627Test

المساهمون: Departament de Salut

المصدر: Scientia

مصطلحات موضوعية: Cribatge (Medicina), Pneumònia - Diagnòstic, DISEASES::Respiratory Tract Diseases::Lung Diseases::Pneumonia, Other subheadings::Other subheadings::/diagnosis, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Mass Screening, ENFERMEDADES::enfermedades respiratorias::enfermedades pulmonares::neumonía, Otros calificadores::Otros calificadores::/diagnóstico, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::cribado sistemático

وصف الملف: application/pdf

العلاقة: Algoritme de detecció de les pneumònies a l’atenció primària. Barcelona: Departament de Salut; 2020.; https://hdl.handle.net/11351/4780Test

الإتاحة: https://hdl.handle.net/11351/4780Test

المؤلفون: Programa d'Harmonització Farmacoterapèutica

المساهمون: Departament de Salut

المصدر: Scientia

مصطلحات موضوعية: Medicaments - Assaigs clínics, COVID-19 (Malaltia), Pneumònia - Tractament, DISEASES::Respiratory Tract Diseases::Lung Diseases::Pneumonia, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Infections::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Drug Development::Drug Evaluation, ENFERMEDADES::enfermedades respiratorias::enfermedades pulmonares::neumonía, Otros calificadores::Otros calificadores::Otros calificadores::/tratamiento farmacológico, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::desarrollo de medicamentos::evaluación de medicamentos

وصف الملف: application/pdf

العلاقة: Programa d'Harmonització Farmacoterapèutica, Servei Català de la Salut; Programa d'Harmonització Farmacoterapèutica. Tractament de la pneumònia per SARS-CoV-2. Barcelona: Servei Català de la Salut; 2020.; https://hdl.handle.net/11351/4777Test

الإتاحة: https://hdl.handle.net/11351/4777Test

المؤلفون: Ulm, Lena, Hoffmann, Sarah, Nabavi, Darius, Hermans, Marcella, Mackert, Bruno-Marcel, Hamilton, Frank, Montaner Villalonga, Joan, Bustamante Rangel, Alejandro

المساهمون: Institut Català de la Salut, Ulm L NeuroCure Clinical Research Center, Charité – Universitaetsmedizin Berlin, Berlin, Germany. Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia. Department of Neurology and Center for Stroke Research Berlin, Charité – Universitaetsmedizin Berlin, Berlin, Germany. Hoffmann S NeuroCure Clinical Research Center, Charité – Universitaetsmedizin Berlin, Berlin, Germany. Department of Neurology and Center for Stroke Research Berlin, Charité – Universitaetsmedizin Berlin, Berlin, Germany. Nabavi D, Hermans M Department of Neurology, Vivantes Klinikum Neukoelln, Berlin, Germany. Mackert BM, Hamilton F Department of Neurology, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany. Montaner J, Bustamante A Grup Malalties neurovasculars, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pneumònia, Medicaments - Administració, Infart de miocardi, DISEASES::Respiratory Tract Diseases::Lung Diseases::Pneumonia, Other subheadings::Other subheadings::Other subheadings::/drug therapy, DISEASES::Cardiovascular Diseases::Heart Diseases::Myocardial Ischemia::Myocardial Infarction, ENFERMEDADES::enfermedades respiratorias::enfermedades pulmonares::neumonía, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ENFERMEDADES::enfermedades cardiovasculares::enfermedades cardíacas::isquemia miocárdica::infarto de miocardio

وصف الملف: application/pdf

العلاقة: Frontiers in Neurology;8; http://journal.frontiersin.org/article/10.3389/fneur.2017.00153/fullTest; info:eu-repo/grantAgreement/EC/FP7/201024; info:eu-repo/grantAgreement/EC/FP7/202213; Ulm L, Hoffmann S, Nabavi D, Hermans M, Mackert BM, Hamilton F, et al. The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke. Front Neurol. 2017 Apr 24;8:153.; https://hdl.handle.net/11351/5928Test; 000399981200001

الإتاحة: https://doi.org/10.3389/fneur.2017.00153Test
https://hdl.handle.net/11351/5928Test

المؤلفون: Garcia-Revilla, Juan, Deierborg, Tomas, Venero, Jose Luis, Boza-Serrano, Antonio

المساهمون: [Garcia-Revilla,J, Venero,JL, Boza-Serrano,A] Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain. [Deierborg,T] Department of Experimental Medical Science, Experimental Neuroinflammation Laboratory, BMC, Lund University, Lund, Sweden. [Boza-Serrano,A] Department of Experimental Medical Sciences, Experimental Dementia Research Laboratory, BMC, Lund University, Lund, Sweden., This work was supported by grants from the Swedish Research Council (2019-06333, AB-S), and the Strong Research Environment MultiPark (Multidisciplinary Research in Parkinson’s and Alzheimer’s Disease at Lund University), Bagadilico (Linné consortium sponsored by the Swedish Research Council), the Swedish Alzheimer’s Foundation, Swedish Brain Foundation, A.E. Berger Foundation, Gyllenstiern-ska Krapperup Foundation, the Royal Physiographic Society, Crafoord Foundation, Olle Engkvist Byggmästare Foundation, Wiberg Foundation, G&J Kock Foundation, Stohnes Foundation, and Swedish Dementia Association and the Medical Faculty at Lund University. This perspective was also funded by the Spanish Ministerio de Ciencia, Innovación y Universidades/FEDER/UE RTI2018-098645-B-100, FEDER I+D+i-USE US-1265062, and US-1264806. JG-R has been funded by a grant from the Spanish Ministerio de Economia y Competitividad SAF2015-64171-R (MINECO/FEDER, EU)., Universidad de Sevilla. Departamento de Bioquímica y Biología Molecular, Swedish Research Council, Lund University, Swedish Alzheimer Foundation, Swedish Brain Foundation, Royal Physiographic Society of Lund, Crafoord Foundation, Olle Engkvist Foundation, Ake Wiberg Foundation, Gun and Bertil Stohnes Foundation, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), European Commission, Ministerio de Economía y Competitividad (España)

المصدر: idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Digital.CSIC. Repositorio Institucional del CSIC
Frontiers in Immunology

مصطلحات موضوعية: Galectina 3, Galectin 3, Galectins, Pulmonary Fibrosis, Infecciones por coronavirus, Immunology, Pneumonia, Viral, Peptidyl-Dipeptidase A, Cytokine storm, Severity of Illness Index, Betacoronavirus, Animals, Humans, Galectin-3, Molecular Targeted Therapy, Diseases::Respiratory Tract Diseases::Lung Diseases::Pulmonary Fibrosis [Medical Subject Headings], Pandemics, Inflammation, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines [Medical Subject Headings], Inflamación, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Lectins::Galectins::Galectin 3 [Medical Subject Headings], SARS-CoV-2, COVID-19, Citocinas, Blood Proteins, Biomarker, Prognosis, Fibrosis, Diseases::Respiratory Tract Diseases::Lung Diseases::Pneumonia [Medical Subject Headings], Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [Medical Subject Headings], Perspective, Host-Pathogen Interactions, Spike Glycoprotein, Coronavirus, Disease Progression, biomarker, Cytokines, Angiotensin-Converting Enzyme 2, Biomarcadores ambientales, Coronavirus Infections, Chemicals and Drugs::Biological Factors::Biological Markers::Biomarkers, Pharmacological [Medical Subject Headings], Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation [Medical Subject Headings], Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::24309308ecf04dbc0bc7532cbbd97eb3Test
https://hdl.handle.net/10668/3245Test